Efficacy and Safety of Rituximab Given at Fixed Dose (1000 mg on Days 1 and 15) Compared to the Standard Regimen in Adult's Immune Thrombocytopenia
NCT01727232
·
clinicaltrials.gov ↗
COMPLETED
Status
107
Enrollment
OTHER
Sponsor class
Conditions
Primary Immune Thrombocytopenia
Sponsor
Henri Mondor University Hospital